AzTrials
AzTrials

Hemodynamic MonitoringNIVSNCT05202769

Non-Invasive Vital Signs Monitoring (NIVS) Project

An observational study of Hemodynamic Monitoring and Monitoring, Physiologic, run by Sciberras, Stephen M.D. at 1 site in Malta.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is aimed at non-invasive extraction of cardiovascular and respiratory parameters from red-green-blue (RGB) and thermal imaging cameras from patients in the intensive care unit (ICU) setting. Read more about this study

Who is it for?
Ages 18 to 95 yearsHealthy volunteers can take part
What is being tested?
Video filming
How many people
40 participants
Where
1 siteMalta
Study dates
11 Feb 2022to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 95 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All patients that fit into the inclusion criteria are included in the study regardless of underlying comorbidities or reasons for admission to the ICU.

Who may be able to join

  • age above 18 years and able to provide consent

Who cannot join

  • age under 18 years and known cardiovascular or respiratory diseases

Trial locations and contacts

1 site in 1 country.

Nicole Grech, MD contact

+35625457234

nicole.grech@gov.mt

Malta1 site, 1 recruiting
  • Mater Dei Hospital

    Msida, MSD2090

    Stephen Sciberras, MD, 0035679070978, stephen.sciberras@gov.mt

    Stephen Sciberras, MD

    Recruiting

Other trials in Malta

About this study

This study is aimed at non-invasive extraction of cardiovascular and respiratory parameters from red-green-blue (RGB) and thermal imaging cameras from patients in the intensive care unit (ICU) setting. The main focus of this study is in assessing the feasibility of implementing such a camera-based system for prolonged monitoring of patients, identifying limiting factors which may interfere with accuracy or practical aspects of the system, and postulating solutions to overcoming these.

Read the detailed description

Non-invasive monitoring of vital signs is an area that is gaining increasing popularity in clinical practise due to its advantages of increased comfort to patients and reduced risk of transmission of multidrug resistant organisms. This study aims to assess the feasibility of using RGB cameras and thermal imaging cameras for monitoring of heart rate and rhythm and respiratory rate and rhythm in the intensive care setting.

Videos of patients are taken in the ICU of a Maltese University-affiliated tertiary hospital (Mater Dei Hospital) under varying conditions, including varying light intensity, different patient positions and periods of time where clinical staff are performing regular care tasks and minor interventions such as bloodletting. Patients enrolled will be able to provide consent for the study after being given a detailed explanation of the study aims, data collected, data storage and processing and any other information they may wish to know.

The video data will be analysed via a convolutional neural network which has been previously trained to extract cardiovascular and respiratory parameters from videos taken from healthy volunteers in a non-clinical setting (a laboratory located in the University of Malta). The heart rate and respiratory rate extracted from patient videos are then compared to ground truth data obtained by current gold standard contact monitoring (data collected from Phillips Intellivue monitors used throughout the ICU) and assessed for accuracy. The practicality of setting up a camera-based system in the intensive care setting and potential means of overcoming limitations faced will also be tackled in this study from a qualitative aspect.

Being tested
Video filming
Keywords
Non-invasive monitoring, RGB camera, thermal camera

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Video filmingOther

    Also called RGB and thermal camera imaging

    Video clips taken using RGB and thermal imaging cameras under varying conditions of lighting, movement and procedures taking place.

Study groups in NCT05202769
Study groupRoleWhat they receive
Healthy Volunteers20 healthy volunteers above the age of 18 in a laboratory setting with video clips taken under varying conditions of lighting, distance between the cameras and the participants' faces and with various positions and limb movements involved.
Receives: Other: Video filming
ICU patientsGroup/Cohort Description: 20 patients above the age of 18 years and able to provide consent, admitted to the ICU with various underlying conditions and comorbidities. Video clips are taken under varying conditions of lighting, positions and with ongoing care and procedures.
Receives: Other: Video filming

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Respiratory rate as measured by a camera system

    Measured: 1 day

  2. Heart Rate, as measured by a camera system

    Measured: 1 day

Secondary outcomes (1)
  1. To assess the accuracy of parameters obtained via the camera-based system as compared to the traditional contact monitoring system.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jan 2022
  2. Study start11 Feb 2022
  3. Primary completion31 Dec 2022 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05202769
Sponsor's protocol ID
NIVS
Acronym
NIVS
Status last verified
Oct 2022
First submitted
10 Dec 2021
Last updated
27 Oct 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Hemodynamic Monitoring and Monitoring, Physiologic, run by Sciberras, Stephen M.D. at 1 site in Malta.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Malta. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nicole Grech, MD (+35625457234, nicole.grech@gov.mt), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Respiratory rate as measured by a camera system (time frame: 1 day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2022; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in